Pricing typically follows within 1-2 days after effectiveness. Watch for the final pricing announcement and first day of trading on Nasdaq. Eli Lilly's non-binding interest may reduce public float if it exercises its interest.
Price Chart
Executive Summary
The SEC declared effective TRex Bio's S-1 registration statement for its initial public offering of 8,333,334 shares of common stock, with an expected price range of $14.00 to $16.00 per share. The company will list on Nasdaq under the ticker TRXB, and Eli Lilly has indicated a non-binding interest to purchase up to 19.9% of post-IPO shares. This EFFECT notice confirms the IPO can proceed to pricing, typically within 1-2 days.
Key Facts
- IPO of 8,333,334 shares of common stock declared effective on October 8, 2026
- Expected price range: $14.00 to $16.00 per share
- Underwriters include J.P. Morgan, Evercore ISI, Cantor, Stifel, Wedbush PacGrow
- Eli Lilly has indicated a non-binding interest to purchase up to 19.9% of post-IPO shares
- Nasdaq listing under ticker TRXB contingent on offering completion
- Underwriters have a 30-day option to purchase up to an additional 1,250,000 shares
Financial Impact
Estimated gross proceeds to TRex Bio: between $116,666,676 and $133,333,344 (midpoint ~$14.00) before expenses, before underwriting discounts and commissions
Risk Factors
- IPO pricing may fall below the $14.00-$16.00 range if market conditions
- Eli Lilly's non-binding interest is not a binding commitment
- No prior public market exists for TRXB shares
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003188 |
| Document: 9999999995-26-003188-index.html | 9999999995-26-003188 |
| Document: 9999999995-26-003188.txt | 9999999995-26-003188 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | SC 13G | $14.80 $14.44 | ▼ −2.43% | ▼ −2.77% | $13.79 (−6.82%) |
Oct 16, 2026 11d ago | SC 13D | $14.80 $14.44 | ▼ −2.43% | ▼ −2.77% | $13.79 (−6.82%) |
Oct 16, 2026 11d ago | SC 13D | $14.01 $14.80 | ▲ +5.64% | ▲ +5.22% | $13.79 (−1.57%) |
Oct 15, 2026 12d ago | Insider Cluster | $14.01 $14.80 | ▲ +5.64% | ▲ +5.22% | $13.79 (−1.57%) |
Oct 15, 2026 12d ago | SC 13G | $14.16 $14.01 | ▼ −1.06% | ▲ +0.05% | $13.79 (−2.61%) |
Oct 13, 2026 14d ago | Press Release | $13.50 $14.16 | ▲ +4.89% | ▲ +4.60% | $13.79 (+2.15%) |
Oct 9, 2026 18d ago | 424B4 | $14.03 $13.60 | ▼ −3.06% | ▼ −3.05% | $13.79 (−1.71%) |
Oct 9, 2026 18d ago | EFFECT | $14.00 $14.03 | ▲ +0.21% | ▲ +0.27% | $13.79 (−1.50%) |
Oct 8, 2026 18d ago | 3 | $14.00 $14.03 | ▲ +0.21% | ▲ +0.27% | $13.79 (−1.50%) |
Oct 8, 2026 18d ago | 3 | $14.00 $14.03 | ▲ +0.21% | ▲ +0.27% | $13.79 (−1.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers